Pharmacies urged to return sibutramine-based drugs at actual invoice price

Published: 2010-10-19 06:56:00

Updated: 2010-10-19 06:56:00

All pharmacies should be hurry to return sibutramine-containing medicines to related pharmaceutical firms and/or wholesalers based on the actually trade price, the Korean Pharmaceutical Association said on October 15.

For further information KPA official said proprietors of pharmacy may click ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK